Sanofi SA
Company Profile
Business description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Contact
46, avenue de la Grande Armée
Paris 75017
FRAT: +33 153774000
E: investor.relations@sanofi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
87,994
Sanofi SA News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
stocks
10 best US blue-chip shares to buy for the long term
personal-finance
Can you achieve global diversification with multinational companies?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,022.70 | 28.50 | 0.36% |
| CAC 40 | 8,249.49 | 61.84 | 0.76% |
| DAX 40 | 18,820.83 | 134.23 | 0.72% |
| Dow JONES (US) | 39,387.76 | 331.37 | 0.85% |
| FTSE 100 | 8,450.35 | 69.00 | 0.82% |
| HKSE | 18,963.68 | 425.87 | 2.30% |
| NASDAQ | 16,346.26 | 43.51 | 0.27% |
| Nikkei 225 | 38,229.11 | 155.13 | 0.41% |
| NZX 50 Index | 11,755.17 | 8.59 | 0.07% |
| S&P 500 | 5,214.08 | 26.41 | 0.51% |
| S&P/ASX 200 | 7,749.00 | 27.40 | 0.35% |
| SSE Composite Index | 3,154.55 | 0.23 | 0.01% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.04 | 0.00 | 10.00% |
| Imugene Ltd IMU | 0.08 | 0.01 | 7.14% |
| Jupiter Mines Ltd JMS | 0.33 | 0.04 | 11.86% |
| Core Lithium Ltd CXO | 0.15 | 0.01 | 3.45% |
| De Grey Mining Ltd DEG | 1.23 | 0.02 | -1.33% |
| Telstra Group Ltd TLS | 3.66 | 0.02 | 0.55% |
| Lake Resources NL LKE | 0.07 | 0.00 | 4.84% |
| Liontown Resources Ltd LTR | 1.40 | 0.00 | 0.00% |
| Pilbara Minerals Ltd PLS | 4.14 | 0.03 | -0.72% |
| Base Resources Ltd BSE | 0.26 | 0.01 | 4.08% |